| Financial Year |
March 31 2023 |
| Monetary Funds |
177,286,084.25 |
| Held-for-trading Financial Assets |
621,957,468.78 |
| Notes Receivable |
164,600,934.65 |
| Accounts Receivable |
404,302,684.52 |
| Advances to Suppliers |
6,137,900.02 |
| Other Receivables |
1,141,493.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
290,116,832.79 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
23,486,364.43 |
| Total Current Assets |
1,772,520,573.24 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
32,101,983.35 |
| Investment Properties |
-- |
| Fixed Assetes |
1,093,051,966.06 |
| Under-construction Projects |
297,181,991.69 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
126,265,924.21 |
| R&D expenses |
-- |
| Goodwill |
14,804,472.26 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
84,132,404.59 |
| Other Non-Current Assets |
36,743,381.45 |
| Sub-Total of Non-Current Assets |
1,684,751,407.72 |
| Total Assets |
3,457,271,980.96 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
164,548,945.59 |
| Accounts Payable |
227,298,660.73 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,942,136.08 |
| Taxes Payable |
9,369,418.99 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,181,505.12 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,889,889.58 |
| Other Current Liabilities |
18,750,484.60 |
| Sub-Total of Current Liabilities |
497,700,005.51 |
| Long-term Loans |
-- |
| Bonds Payable |
503,140,321.02 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
148,679.97 |
| Deferred Income Tax Liabilities |
68,570,570.34 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
754,360,237.63 |
| Total Liabilities |
1,252,060,243.14 |
| Paid-In Capital(Or Share Stock) |
200,016,668.00 |
| Capital Surplus |
685,289,953.96 |
| Surplus Reserve |
112,845,261.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,060,000,680.66 |
| Minority Stockholder's Interest |
10,587,822.12 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,194,623,915.70 |
| Owner's Equity（Stockholder's Equity） |
2,205,211,737.82 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,457,271,980.96 |
